Write a postmarketing experience report for Module 5

What belongs in a Module 5 postmarketing experience report?

Summarize the marketed product, markets and reporting period, estimated exposure, significant observations and relevant actions, with the methods and limitations needed to interpret them. Keep reports, events and people distinct. The 5.3.6 narrative does not replace study reports or separate safety submissions that apply to the product.

Before you begin

Marketing-experience summaries for a product already marketed, as part of a Module 5 evidence package. Separate periodic or expedited reporting obligations need their own assessment.

What you will prepare: A traceable marketing-experience account with defined periods, products, exposure estimates and significant safety observations.

Define the marketed product and reporting window

Establish where and when the product has been marketed, the relevant formulations and indications, and the period represented by the report. M4E places reports summarizing marketing experience, including significant safety observations, in 5.3.6 for currently marketed products. A product with no marketing history needs an accurate disposition, not an invented zero-event experience report.

Collect the relevant pharmacovigilance assessments, exposure estimates and their methodology, market history, regulatory actions and supporting clinical or observational reports. Distinguish data already available before the cutoff from later information considered separately. Identify the responsible safety and regulatory owners before selecting what belongs in this submission.

Describe the evidence source before interpreting its counts

As a practical reporting method, organize the account by period, market/product context, estimated exposure, important findings and their assessment. Explain how exposure was estimated and what the units represent. Sales-derived exposure, prescriptions and unique patients measure different things; avoid presenting an estimate as a directly observed participant count.

For spontaneous reports, describe the source, inclusion rules and handling of duplicates or follow-up information. Separate counts of reports from counts of events and people. Discuss important limitations in ascertainment and denominator information before making frequency comparisons. Incorporate relevant regulatory or labeling actions with their actual dates and status rather than implying that every signal has a settled causal interpretation.

Do not turn an absence of reports into an absence of risk

Fictional exercise: no reports of a particular event were retrieved from a defined database period, and the draft calls the event impossible in clinical use. Narrow the statement to the search and observation actually performed, describe its limitations, and have the safety owner assess the evidence. Underreporting and uncertain exposure prevent that categorical conclusion.

Reconcile the final report with the clinical safety summary, including cutoff, product scope and any significant observations. A study performed after approval is still a study report and needs placement according to its design and purpose; it is not automatically only marketing experience. Likewise, this Module 5 narrative does not replace separate periodic or expedited safety submissions when those apply.

Define the unit behind each postmarketing count

Use a count map before writing a frequency statement. Each measure describes a different part of the evidence.

Interpretation exercise: report counts rise after a change in collection or awareness. Describe both the counts and the change before suggesting that underlying event frequency rose. Have the safety team assess the evidence; the numerator alone cannot resolve that question.

Reconcile significant findings and cutoffs with the clinical safety summary. If a postapproval clinical study contributes evidence, use the clinical study listing to preserve its separate report identity and appropriate placement.

Frequently asked questions

Sources and revisions

Requirements, source recommendations and editorial preparation advice have different roles. Review the scope and revision of the source you use.

Related guides